ConductScience.org, home

Paper40667402

Predictive Value of High-Sensitivity CRP Level on the No-Reflow Phenomenon in STEMI Patients.

Krasniqi X and 4 others. Cardiol Res Pract, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Predictive Value of High-Sensitivity CRP Level on the No-Reflow Phenomenon in STEMI Patients. Papers, record 40667402. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40667402

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Predictive Value of High-Sensitivity CRP Level on the No-Reflow Phenomenon in STEMI Patients.
PubMed
Journal
Cardiol Res Pract
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-07-18
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128886621
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).
Eur Heart J2018https://conductscience.org/library/papers/28886621PubMed
223111142Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction.Am J Cardiol2013https://conductscience.org/library/papers/23111142PubMed
337171284Association between apelin-12 and creatine kinase-MB, depending on success of reperfusion in STEMI patients.Cardiovasc J Afr2024https://conductscience.org/library/papers/37171284PubMed
431275641Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection.Cardiol Res Pract2019https://conductscience.org/library/papers/31275641PubMed
535456326"No-Reflow" Phenomenon: A Contemporary Review.J Clin Med2022https://conductscience.org/library/papers/35456326PubMed
619327529Cyclophosphamide protects against myocardial ischemia/reperfusion injury in rats: one of the therapeutic targets is high sensitivity C-reactive protein.J Thorac Cardiovasc Surg2009https://conductscience.org/library/papers/19327529PubMed
737832116High CRP-albumin ratio is associated high thrombus burden in patients with newly diagnosed STEMI.Medicine (Baltimore)2023https://conductscience.org/library/papers/37832116PubMed
826616729The no-reflow phenomenon: State of the art.Arch Cardiovasc Dis2015https://conductscience.org/library/papers/26616729PubMed
933593616Predictive Value of CAR for In-Hospital Mortality in Patients with COVID-19 Pneumonia: A Retrospective Cohort Study.Arch Med Res2021https://conductscience.org/library/papers/33593616PubMed
10376226542023 ESC Guidelines for the management of acute coronary syndromes.Eur Heart J2023https://conductscience.org/library/papers/37622654PubMed
1137025078The Role of Artificial Intelligence in Coronary Artery Disease and Atrial FibrillationBalkan Med J2023https://conductscience.org/library/papers/37025078PubMed
1222764104Mitochondrial ROS production and subsequent ERK phosphorylation are necessary for temperature preconditioning of isolated ventricular myocytes.Cell Death Dis2012https://conductscience.org/library/papers/22764104PubMed
1339263796Comparison of inflammatory markers for the prediction of atrial fibrillation recurrence following cryoablation.Biomark Med2024https://conductscience.org/library/papers/39263796PubMed
1437623467Risk Factors of Suboptimal Coronary Blood Flow after a Percutaneous Coronary Intervention in Patients with Acute Anterior Wall Myocardial Infarction.J Pers Med2023https://conductscience.org/library/papers/37623467PubMed
1529694958Current Mechanistic Concepts in Ischemia and Reperfusion Injury.Cell Physiol Biochem2018https://conductscience.org/library/papers/29694958PubMed
1630571511Fourth Universal Definition of Myocardial Infarction (2018).Circulation2018https://conductscience.org/library/papers/30571511PubMed
1719631649CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-kappaB and ERK 1/2 MAPK pathway.FEBS Lett2009https://conductscience.org/library/papers/19631649PubMed
1816624260C-reactive protein in atherosclerosis: A causal factor?Cardiovasc Res2006https://conductscience.org/library/papers/16624260PubMed
1938661580
Relationship between the Fibrinogen/Albumin Ratio and Microvascular Perfusion in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevated Myocardial Infarction: A Prospective Study.
Arq Bras Cardiol2023https://conductscience.org/library/papers/38661580PubMed
2025832424C-reactive protein stimulates RAGE expression in human coronary artery endothelial cells in vitro via ROS generation and ERK/NF-κB activation.Acta Pharmacol Sin2015https://conductscience.org/library/papers/25832424PubMed

See all 29 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42428482Association between remnant cholesterol inflammation Index and in-hospital New-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction.Front Cardiovasc Med2026https://conductscience.org/library/papers/42428482PubMed
42351811Inflammation-Based C-Reactive Protein-to-Albumin Ratio for No-Reflow Prediction in STEMI.Biomedicines2026https://conductscience.org/library/papers/42351811PubMed
41682744Admission EASIX Score Predicts Coronary No-Reflow and In-Hospital Mortality in STEMI Patients Undergoing Primary PCI.J Clin Med2026https://conductscience.org/library/papers/41682744PubMed
41598248Predictive Value of Apelin-36 for No-Reflow Phenomenon in STEMI Patients.Life (Basel)2026https://conductscience.org/library/papers/41598248PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CMPK151727PubTator's text mininghttps://conductscience.org/library/genes/51727NCBI Gene
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40667402

GET https://conductscience.org/api/papers/v1/40667402/references?page=2